Cat. # RR01

Product Uses Include

• Rap1a biochemistry
• Rap1a GTPase assays
• Rap1a nucleotide exchange assays
• Rap1a binding studies
  
  

Material
The human Rap1a protein has been produced in a bacterial expression system. The protein is supplied as a lyophilized powder. When it is reconstituted in distilled water to 1 mg/ml, the protein is in the following buffer: 2 mM Tris pH 7.6, 0.5 mM MgCl₂, 0.5% sucrose, 0.1% dextran. Protein concentration is determined by the Precision Red Advanced Protein Assay Reagent, Cat. # ADV02.

The recombinant protein is approximately 26 kDa, consisting of the Rap1a protein plus a linker and a 6X His tag in the amino-terminus.

For many other purified small G-proteins, see our main small G-protein product page.

Purity
Purity is determined by scanning densitometry of proteins on SDS-PAGE gels. Rap1a samples are >90% pure (Figure 1).

Figure 1: Rap1a His-tagged protein purity determination. A 10 µg sample of RR01 (molecular weight approx. 26 kDa) was separated by electrophoresis in a 12% SDS-PAGE system. The protein was stained with Coomassie Blue.

Biological Activity
The biological activity of Rap1a is determined from its ability to exchange GDP for GTP. EDTA is used to sequester magensium ions from the Rap1a protein, thereby stimulating nucleotide exchange activity. The RhoGEF exchange assay Biochem Kit™ (Cat. # BK100) is used to monitor the exchange (Figure 2).

Figure 2: Rap1a GTP exchange assay using BK100. Rap1a protein (1 µM) was mixed with exchange buffer and aliquoted to four wells of a 96-well half area plate. After 5 cycles of reading in a fluorimeter, EDTA was added to 40 mM in the test samples and Milli-Q water to the control samples. Reactions were monitored for 30 min.